Clinical Trial

Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated February 28, 2024 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
To investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2015-08-17; most recent amendment 2024-02-27.
Trial Details
NCT Number NCT02526797
Lead Sponsor Herlev Hospital
Conditions Prostatic Neoplasms
Enrollment 150 participants
Start Date 2013-01
Primary Completion 2026-07 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-02-28